Could this ASX 200 share be in for a $1.7 billion boost?

The ASX 200 healthcare stock is reported to be considering selling some high value assets.

| More on:
A man sits in contemplation on his sofa looking at his phone as though he has just heard some serious or interesting news.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

S&P/ASX 200 Index (ASX: XJO) listed Ramsay Health Care Ltd (ASX: RHC) is recovering from the two-year lows its share price hit on 26 September.

That low point came after takeover negotiations with a consortium of financial investors led by KKR failed to reach an agreement.

The ASX 200 healthcare share continued to trade lower over the following days. But the company's share price has rebounded 14% since 28 September. Shares are currently swapping hands for $64.26 apiece.

Some of that lift may be driven by speculation that Ramsay could be planning to sell a goodly portion of its property assets alongside its stake in European hospital operator Ramsay Sante.

A possible $1.7 billion boost for this ASX 200 stock

Citing unnamed sources close to Ramsay, The Australian reports that it understands the ASX 200 healthcare stock is weighing up selling 25% of its real estate assets.

Ramsay Sante, which operates 210 facilities – including primary care units, specialist clinics, and hospitals in Denmark, Norway, Sweden, and Italy – may also be in the mix.

Should Ramsay Healthcare opt to sell its $1.7 billion majority stake in Ramsay Sante and property assets, Macquarie analysts believe the company's share price could see a healthy boost, improving the stock's return on invested capital.

According to Macquarie (courtesy of The Australian):

Applying a multiple of 12.5 times earnings before interest, tax, depreciation and amortisation for the Australian business, combined with Ramsay Sante sale proceeds, would provide a valuation of about $72.00, 15 per cent ahead of the current share price.

With some recent gains posted by the ASX 200 healthcare company, a $72.00 valuation represents a 12% premium on the share price at the time of writing.

Ramsay share price snapshot

The Ramsay share price has enjoyed a strong month, up almost 14%. That outpaces the 7% monthly gain posted by the ASX 200.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ramsay Health Care Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A company manager presents the ASX company earnings report to shareholders at an AGM.
Healthcare Shares

Why this $13 billion ASX 200 healthcare stock is surging today

A change in sentiment for the healthcare player.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

This ASX 200 stock hit a 52-week low and a top broker thinks it can rebound

Patient investors may see this stock make a pleasing recovery.

Read more »

A couple smile as they look at a pregnancy test.
Healthcare Shares

Why this sold-off ASX healthcare share could be an exciting dividend buy

This could be a healthy stock for dividends.

Read more »

a smiling woman sits at her computer at home with a coffee alongside her, as if pleased with her investments.
Healthcare Shares

Is CSL the best ASX 100 share to buy now?

Bell Potter has good things to say about this blue chip star.

Read more »

Scientists in a laboratory look at a computer screen with anticipation on their faces representing a potential change in the performance of ASX biotech shares in FY23
Healthcare Shares

Down 10% in a month, are CSL shares feeling the sting of a potential disruption?

Brokers are still bullish.

Read more »

One girl leapfrogs over her friend's back.
Healthcare Shares

Doubled in a year! Does this booming ASX share have another 24% upside?

Let's take a look.

Read more »

A young woman holds an open book over her head with a round mouthed expression as if to say oops as she looks at her computer screen in a home office setting with a plant on the desk and shelves of books in the background.
Healthcare Shares

This ASX All Ords share is diving 18% as inflation pain draws blood

This healthcare company delivered a trading update at its annual general meeting today.

Read more »

Shot of a young scientist using a digital tablet while working in a lab.
Healthcare Shares

Up 427% this year, why today is a big day for Mesoblast shares

Why is everyone talking about Mesoblast shares on Friday?

Read more »